[Lennox-Gastaut syndrome--clinical course and therapy]. 1994

R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
Zespołu Neurologii Dzieciecej, Zdrowia Dziecka Szpitala-Pomnika.

Clinical course and results of therapy were analysed in the group of 92 children, aged between 3 and 9 years, with diagnosed Lennox-Gastaut syndrome. The obtained results of an analysis have shown that Lennox-Gastaut syndrome origin is not clear--causative factor can not be established in 1/3 of patients whereas in 1/2 of them abnormal course of pregnancy and perinatal period is noted. Together with seizures of various origin, other focal neurological symptoms, mental retardation and abnormalities in CT scans of the brain are frequently seen in patients with Lennox-Gastaut syndrome. Clinical course, prognosis and results of therapy are largely dependent on the degree of mental development before the onset of epileptic seizures, course of pregnancy and perinatal period, and the time of therapy. Children with Lennox-Gastaut syndrome require relative polytherapy in which valproic acid derivatives are predominating together with benzodiazepines, and temporary corticosteroids. An improvement was achieved in about 30% of the treated children. Prognosis in the remaining 70% of children is rather poor. Irregular administration of drugs, frequent changes of anti-epileptic agents, too low doses and abnormal environmental effects (abnormal parental attitudes) affect the results of therapy. An emphasis is on the poor prognosis in Lennox-Gastaut syndrome proceeded with West syndrome.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 2011, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
February 2021, Epilepsy & behavior : E&B,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 2002, Advances in experimental medicine and biology,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
October 1997, Pediatric neurology,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 2002, Ryoikibetsu shokogun shirizu,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 1999, Revista de neurologia,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
May 1977, Harefuah,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 2002, Journal of child neurology,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
January 2002, Advances in experimental medicine and biology,
R Ignatowicz, and R Michałowicz, and L Ignatowiczowa, and T Kmieć
June 1993, The New England journal of medicine,
Copied contents to your clipboard!